Skip to main content

Mountain Crest Acquisition Corp. II (MCAD)

NASDAQ: MCAD · IEX Real-Time Price · USD
9.98 0.01 (0.10%)
Sep 24, 2021 4:00 PM EDT - Market closed
Market Cap75.42M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out7.56M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume705
Open9.97
Previous Close9.97
Day's Range9.97 - 9.98
52-Week Range9.69 - 10.04
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About MCAD

Mountain Crest Acquisition Corp. II. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

IndustryShell Companies
IPO DateJan 8, 2021
Stock ExchangeNASDAQ
Ticker SymbolMCAD
Full Company Profile

News

Better Therapeutics to Participate in Lake Street's 5th Annual Best Ideas Growth (BIG5) Conference on September 14-15...

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of car...

2 weeks ago - Business Wire

Better Therapeutics Highlights Recent Progress and Updates Outlook Through 2022

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of car...

2 weeks ago - Business Wire

Better Therapeutics Expands Real-World Evidence Study Initiative With Addition of Catalyst Health Network

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardi...

1 month ago - Business Wire

Better Therapeutics, Inc. to Present at the Canaccord Genuity's 41st Annual Growth Conference

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardi...

1 month ago - Business Wire

Better Therapeutics and Colorado Prevention Center Clinical Research Launch Real-World Evidence Study of Prescription...

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardi...

1 month ago - Business Wire

Better Therapeutics to Participate in Cowen 6th Annual FutureHealth Conference

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardi...

3 months ago - Business Wire

INVESTIGATION ALERT: Halper Sadeh LLP Investigates MCAD, CAHC, ROT, MUDS, LATN; Shareholders are Encouraged to Contac...

NEW YORK, April 29, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Mountain Crest Acquisition Corp. II (NASDAQ: MCAD)  c...

Other symbols:CAHCLATNMUDSROT
4 months ago - PRNewsWire

Better Therapeutics Commences Pivotal Study of Prescription Digital Therapeutic for the Treatment of Type 2 Diabetes

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc., (“Better Therapeutics”) a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardi...

5 months ago - Business Wire

Better Therapeutics Launches Real World Evidence Study of Prescription Digital Therapeutic for Type 2 Diabetes

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardi...

5 months ago - Business Wire

Better Therapeutics To Go Public Via Mountain Crest SPAC Deal

Better Therapeutics Inc, a company developing prescription-only smartphone-based treatments for Type 2 diabetes and high blood pressure, has agreed to go public through a merger with a blank-check compa...

5 months ago - Benzinga

Better Therapeutics to Become Publicly Traded Prescription Digital Therapeutics Company via Merger with Mountain Cres...

SAN FRANCISCO & NEW YORK--(BUSINESS WIRE)--Better Therapeutics, Inc. a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic dis...

5 months ago - Business Wire

Mountain Crest Acquisition Corp. II Announces that Common Stock and Rights to Commence Separate Trading on or about M...

New York, N.Y., March 15, 2021 (GLOBE NEWSWIRE) -- March 15, 2021 Mountain Crest Acquisition Corp. II (the “Company”) (NASDAQ: MCADU), a blank check company formed for the purpose of entering into a mer...

6 months ago - GlobeNewsWire

Mountain Crest Acquisition Corp. II Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its...

New York, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCADU, the “Company”) announced today that the underwriters in its initial public offering, pursuant to the terms...

8 months ago - GlobeNewsWire

Mountain Crest Acquisition Corp. II Announces Closing of $50 Million Initial Public Offering

New York, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCADU, the “Company”) announced today that it closed its initial public offering of 5,000,000 units at $10.00 per...

8 months ago - GlobeNewsWire

Mountain Crest Acquisition Corp. II Announces Pricing of $50 Million Initial Public Offering

New York, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCADU, the “Company”) announced today that it priced its initial public offering of 5,000,000 units at $10.00 per...

8 months ago - GlobeNewsWire

North America-focused SPAC Mountain Crest Acquisition II files for a $50 million IPO

Mountain Crest Acquisition II, a blank check company targeting a business in North America with under-researched assets, filed on Monday with the SEC to raise up to $50 million in an initial public offe...

9 months ago - NASDAQ

Mountain Crest Acquisition II IPO Registration Document (S-1)

Mountain Crest Acquisition Corp. II has filed to go public with an IPO on the NASDAQ.

9 months ago - SEC